$ALXN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALEXION PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ALEXION PHARMACEUTICALS, INC.. Get notifications about new insider transactions in ALEXION PHARMACEUTICALS, INC. for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 22 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 15 2015 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Sell | S | 186.97 | 34 | 6,357 | 77,889 | 77.9 K to 77.9 K (-0.04 %) |
Dec 15 2015 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Grant | A | 96.35 | 3,425 | 329,999 | 77,923 | 74.5 K to 77.9 K (+4.60 %) |
Dec 15 2015 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Grant | A | 85.75 | 3,237 | 277,573 | 74,498 | 71.3 K to 74.5 K (+4.54 %) |
Dec 15 2015 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Grant | A | 49.43 | 5,572 | 275,424 | 71,261 | 65.7 K to 71.3 K (+8.48 %) |
Dec 15 2015 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Grant | A | 26.64 | 7,932 | 211,308 | 65,689 | 57.8 K to 65.7 K (+13.73 %) |
Dec 15 2015 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Grant | A | 16.83 | 12,276 | 206,605 | 57,757 | 45.5 K to 57.8 K (+26.99 %) |
Dec 15 2015 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Grant | A | 18.01 | 13,000 | 234,130 | 45,481 | 32.5 K to 45.5 K (+40.02 %) |
Dec 15 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Sell | S | 188.13 | 4,352 | 818,742 | 727,940 | 732.3 K to 727.9 K (-0.59 %) |
Dec 15 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Sell | S | 187.41 | 16,967 | 3,179,785 | 732,292 | 749.3 K to 732.3 K (-2.26 %) |
Dec 15 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Gift | G | 0.00 | 34,595 | 0 | 749,259 | 783.9 K to 749.3 K (-4.41 %) |
Dec 15 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Gift | G | 0.00 | 22,597 | 0 | 783,854 | 806.5 K to 783.9 K (-2.80 %) |
Dec 15 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Gift | G | 0.00 | 42,637 | 0 | 806,451 | 849.1 K to 806.5 K (-5.02 %) |
Dec 15 2015 | ALXN | ALEXION PHARMACEUT ... | Veneman Ann M | Director | Sell | S | 187.48 | 895 | 167,795 | 3,252 | 4.1 K to 3.3 K (-21.58 %) |
Dec 15 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 185.54 | 25 | 4,639 | 41,340 | 41.4 K to 41.3 K (-0.06 %) |
Dec 15 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 182.65 | 918 | 167,673 | 41,365 | 42.3 K to 41.4 K (-2.17 %) |
Dec 08 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Sell | S | 190.16 | 23,866 | 4,538,359 | 849,088 | 873 K to 849.1 K (-2.73 %) |
Dec 08 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Sell | S | 189.69 | 15,238 | 2,890,496 | 872,954 | 888.2 K to 873 K (-1.72 %) |
Dec 08 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Sell | S | 187.88 | 100 | 18,788 | 888,192 | 888.3 K to 888.2 K (-0.01 %) |
Dec 08 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Sell | S | 187.18 | 10,478 | 1,961,272 | 888,292 | 898.8 K to 888.3 K (-1.17 %) |
Dec 08 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Sell | S | 185.30 | 20,318 | 3,764,925 | 898,770 | 919.1 K to 898.8 K (-2.21 %) |
Dec 08 2015 | ALXN | ALEXION PHARMACEUT ... | Islam Saqib | EVP, Chief Strat & ... | Sell | S | 190.00 | 950 | 180,500 | 36,385 | 37.3 K to 36.4 K (-2.54 %) |
Nov 30 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Option Exercise | M | 22.90 | 35,000 | 801,500 | 328,950 | |
Nov 30 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Sell | S | 182.96 | 500 | 91,480 | 919,088 | 919.6 K to 919.1 K (-0.05 %) |
Nov 30 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Sell | S | 182.45 | 21,125 | 3,854,256 | 919,588 | 940.7 K to 919.6 K (-2.25 %) |
Nov 30 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Sell | S | 181.47 | 7,774 | 1,410,748 | 940,713 | 948.5 K to 940.7 K (-0.82 %) |
Nov 30 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Sell | S | 180.29 | 5,601 | 1,009,804 | 948,487 | 954.1 K to 948.5 K (-0.59 %) |
Nov 30 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Buy | M | 22.90 | 35,000 | 801,500 | 954,088 | 919.1 K to 954.1 K (+3.81 %) |
Nov 12 2015 | ALXN | ALEXION PHARMACEUT ... | Thiel Carsten | EVP, Chief Commerci ... | Sell | S | 173.34 | 3,000 | 520,020 | 28,018 | 31 K to 28 K (-9.67 %) |
Nov 04 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Option Exercise | M | 22.90 | 35,000 | 801,500 | 363,950 | |
Nov 04 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Sell | S | 180.12 | 35,000 | 6,304,200 | 919,088 | 954.1 K to 919.1 K (-3.67 %) |
Nov 04 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Grant | A | 22.90 | 35,000 | 801,500 | 954,088 | 919.1 K to 954.1 K (+3.81 %) |
Nov 04 2015 | ALXN | ALEXION PHARMACEUT ... | Islam Saqib | EVP, Chief Strat & ... | Sell | S | 180.00 | 975 | 175,500 | 37,335 | 38.3 K to 37.3 K (-2.55 %) |
Nov 04 2015 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 178.73 | 895 | 159,963 | 4,645 | 5.5 K to 4.6 K (-16.16 %) |
Oct 29 2015 | ALXN | ALEXION PHARMACEUT ... | Islam Saqib | EVP, Chief Strat & ... | Sell | S | 168.44 | 1,558 | 262,430 | 38,310 | 39.9 K to 38.3 K (-3.91 %) |
Oct 08 2015 | ALXN | ALEXION PHARMACEUT ... | Wagner Heidi L | SVP, Global Governm ... | Option Exercise | A | 157.82 | 5,000 | 789,100 | 5,000 | |
Oct 08 2015 | ALXN | ALEXION PHARMACEUT ... | Wagner Heidi L | SVP, Global Governm ... | Grant | A | 0.00 | 1,000 | 0 | 13,458 | 12.5 K to 13.5 K (+8.03 %) |
Oct 05 2015 | ALXN | ALEXION PHARMACEUT ... | Thiel Carsten | EVP, Chief Commerci ... | Option Exercise | A | 157.82 | 6,700 | 1,057,394 | 6,700 | |
Oct 05 2015 | ALXN | ALEXION PHARMACEUT ... | Thiel Carsten | EVP, Chief Commerci ... | Grant | A | 0.00 | 2,000 | 0 | 31,018 | 29 K to 31 K (+6.89 %) |
Sep 10 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Sell | S | 180.10 | 1,050 | 189,105 | 919,088 | 920.1 K to 919.1 K (-0.11 %) |
Sep 10 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Grant | A | 22.90 | 1,050 | 24,045 | 920,138 | 919.1 K to 920.1 K (+0.11 %) |
Sep 10 2015 | ALXN | ALEXION PHARMACEUT ... | O'Neill Julie | EVP. Global Operati ... | Sell | S | 171.76 | 647 | 111,129 | 21,443 | 22.1 K to 21.4 K (-2.93 %) |
Sep 10 2015 | ALXN | ALEXION PHARMACEUT ... | Miller Edward | SVP, Chief Complian ... | Sell | S | 179.55 | 366 | 65,715 | 6,464 | 6.8 K to 6.5 K (-5.36 %) |
Sep 10 2015 | ALXN | ALEXION PHARMACEUT ... | Thiel Carsten | SVP, EMEA & Asia Pa ... | Sell | S | 170.88 | 12 | 2,051 | 29,018 | 29 K to 29 K (-0.04 %) |
Sep 10 2015 | ALXN | ALEXION PHARMACEUT ... | Thiel Carsten | SVP, EMEA & Asia Pa ... | Sell | S | 169.15 | 800 | 135,320 | 29,030 | 29.8 K to 29 K (-2.68 %) |
Sep 03 2015 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | EVP, Chief HR Offic ... | Sell | S | 168.62 | 305 | 51,429 | 27,156 | 27.5 K to 27.2 K (-1.11 %) |
Aug 11 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 190.01 | 135 | 25,651 | 42,283 | 42.4 K to 42.3 K (-0.32 %) |
Aug 11 2015 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | EVP, Chief HR Offic ... | Sell | S | 190.01 | 163 | 30,972 | 27,461 | 27.6 K to 27.5 K (-0.59 %) |
Aug 11 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 190.01 | 329 | 62,513 | 143,187 | 143.5 K to 143.2 K (-0.23 %) |
Aug 11 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Sell | S | 190.01 | 1,003 | 190,580 | 919,088 | 920.1 K to 919.1 K (-0.11 %) |
Aug 05 2015 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Option Exercise | M | 176.80 | 15,375 | 2,718,300 | 33,825 | |
Aug 05 2015 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Option Exercise | M | 104.86 | 28,125 | 2,949,188 | 37,500 | |
Aug 05 2015 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 195.19 | 8,882 | 1,733,678 | 32,893 | 41.8 K to 32.9 K (-21.26 %) |
Aug 05 2015 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 196.48 | 17,518 | 3,441,937 | 41,775 | 59.3 K to 41.8 K (-29.54 %) |
Aug 05 2015 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 197.24 | 17,100 | 3,372,804 | 59,293 | 76.4 K to 59.3 K (-22.38 %) |
Aug 05 2015 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Buy | M | 176.80 | 15,375 | 2,718,300 | 76,393 | 61 K to 76.4 K (+25.20 %) |
Aug 05 2015 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Buy | M | 104.86 | 28,125 | 2,949,188 | 61,018 | 32.9 K to 61 K (+85.50 %) |
Aug 05 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 196.52 | 612 | 120,270 | 143,516 | 144.1 K to 143.5 K (-0.42 %) |
Aug 05 2015 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | EVP, Chief HR Offic ... | Sell | S | 196.52 | 185 | 36,356 | 27,624 | 27.8 K to 27.6 K (-0.67 %) |
Aug 05 2015 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 196.52 | 675 | 132,651 | 166,646 | 167.3 K to 166.6 K (-0.40 %) |
Aug 05 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Sell | S | 196.52 | 2,200 | 432,344 | 920,091 | 922.3 K to 920.1 K (-0.24 %) |
Aug 05 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Option Exercise | M | 92.65 | 10,000 | 926,500 | 45,000 | |
Aug 05 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Buy | M | 92.65 | 10,000 | 926,500 | 42,418 | 32.4 K to 42.4 K (+30.85 %) |
Aug 05 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 199.05 | 3,436 | 683,936 | 32,418 | 35.9 K to 32.4 K (-9.58 %) |
Aug 05 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 198.12 | 6,574 | 1,302,441 | 35,854 | 42.4 K to 35.9 K (-15.49 %) |
Aug 05 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Buy | M | 92.65 | 10,000 | 926,500 | 42,428 | 32.4 K to 42.4 K (+30.84 %) |
Jul 24 2015 | ALXN | ALEXION PHARMACEUT ... | BAKER FELIX | Director | Option Exercise | A | 206.16 | 2,329 | 480,147 | 2,329 | |
Jul 24 2015 | ALXN | ALEXION PHARMACEUT ... | BAKER FELIX | Director | Grant | A | 0.00 | 696 | 0 | 6,103,727 | 6.1 M to 6.1 M (+0.01 %) |
Jul 24 2015 | ALXN | ALEXION PHARMACEUT ... | BAKER FELIX | Director | Grant | A | 0.00 | 696 | 0 | 506,861 | 506.2 K to 506.9 K (+0.14 %) |
Jun 24 2015 | ALXN | ALEXION PHARMACEUT ... | BAKER FELIX | Director | Grant | A | 0.00 | 6,103,033 | 0 | 6,103,033 | 0 to 6.1 M |
Jun 24 2015 | ALXN | ALEXION PHARMACEUT ... | BAKER FELIX | Director | Grant | A | 0.00 | 506,166 | 0 | 506,166 | 0 to 506.2 K |
Jun 24 2015 | ALXN | ALEXION PHARMACEUT ... | BAKER FELIX | Director | Grant | A | 0.00 | 94,412 | 0 | 94,412 | 0 to 94.4 K |
Jun 24 2015 | ALXN | ALEXION PHARMACEUT ... | BAKER FELIX | Director | Grant | A | 0.00 | 66,154 | 0 | 66,154 | 0 to 66.2 K |
Jun 24 2015 | ALXN | ALEXION PHARMACEUT ... | BAKER FELIX | Director | Grant | A | 0.00 | 65,811 | 0 | 65,811 | 0 to 65.8 K |
Jun 19 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Sell | S | 179.63 | 27,835 | 5,000,001 | 922,291 | 950.1 K to 922.3 K (-2.93 %) |
Jun 12 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 170.00 | 914 | 155,380 | 32,428 | 33.3 K to 32.4 K (-2.74 %) |
May 22 2015 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 160.33 | 4,056 | 650,298 | 32,893 | 36.9 K to 32.9 K (-10.98 %) |
May 22 2015 | ALXN | ALEXION PHARMACEUT ... | Monnet Dominique | SVP, Chief Marketin ... | Sell | S | 162.40 | 256 | 41,574 | 8,787 | 9 K to 8.8 K (-2.83 %) |
May 08 2015 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | A | 155.01 | 2,343 | 363,188 | 2,343 | |
May 08 2015 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Grant | A | 0.00 | 700 | 0 | 5,540 | 4.8 K to 5.5 K (+14.46 %) |
May 08 2015 | ALXN | ALEXION PHARMACEUT ... | Veneman Ann M | Director | Option Exercise | A | 155.01 | 2,343 | 363,188 | 2,343 | |
May 08 2015 | ALXN | ALEXION PHARMACEUT ... | Veneman Ann M | Director | Grant | A | 0.00 | 700 | 0 | 4,147 | 3.4 K to 4.1 K (+20.31 %) |
May 08 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Option Exercise | A | 155.01 | 2,343 | 363,188 | 2,343 | |
May 08 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Grant | A | 0.00 | 700 | 0 | 950,126 | 949.4 K to 950.1 K (+0.07 %) |
May 08 2015 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Option Exercise | A | 155.01 | 2,343 | 363,188 | 2,343 | |
May 08 2015 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Grant | A | 0.00 | 700 | 0 | 13,486 | 12.8 K to 13.5 K (+5.47 %) |
May 08 2015 | ALXN | ALEXION PHARMACEUT ... | BURNS M MICHELE | Director | Option Exercise | A | 155.01 | 2,343 | 363,188 | 2,343 | |
May 08 2015 | ALXN | ALEXION PHARMACEUT ... | BURNS M MICHELE | Director | Grant | A | 0.00 | 700 | 0 | 1,488 | 788 to 1.5 K (+88.83 %) |
May 08 2015 | ALXN | ALEXION PHARMACEUT ... | Mollen John T | Director | Option Exercise | A | 155.01 | 2,343 | 363,188 | 2,343 | |
May 08 2015 | ALXN | ALEXION PHARMACEUT ... | Mollen John T | Director | Grant | A | 0.00 | 700 | 0 | 1,530 | 830 to 1.5 K (+84.34 %) |
May 08 2015 | ALXN | ALEXION PHARMACEUT ... | Brennan David R | Director | Option Exercise | A | 155.01 | 2,343 | 363,188 | 2,343 | |
May 08 2015 | ALXN | ALEXION PHARMACEUT ... | Brennan David R | Director | Grant | A | 0.00 | 700 | 0 | 1,968 | 1.3 K to 2 K (+55.21 %) |
May 08 2015 | ALXN | ALEXION PHARMACEUT ... | COUGHLIN CHRISTOPHER J | Director | Option Exercise | A | 155.01 | 2,343 | 363,188 | 2,343 | |
May 08 2015 | ALXN | ALEXION PHARMACEUT ... | COUGHLIN CHRISTOPHER J | Director | Grant | A | 0.00 | 700 | 0 | 1,468 | 768 to 1.5 K (+91.15 %) |
May 08 2015 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Option Exercise | A | 155.01 | 2,343 | 363,188 | 2,343 | |
May 08 2015 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Grant | A | 0.00 | 700 | 0 | 32,481 | 31.8 K to 32.5 K (+2.20 %) |
Apr 30 2015 | ALXN | ALEXION PHARMACEUT ... | Islam Saqib | EVP, Chief Strat & ... | Sell | S | 181.57 | 6,032 | 1,095,230 | 39,868 | 45.9 K to 39.9 K (-13.14 %) |
Apr 02 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Option Exercise | A | 173.30 | 49,275 | 8,539,358 | 49,275 | |
Apr 02 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Grant | A | 0.00 | 11,270 | 0 | 144,128 | 132.9 K to 144.1 K (+8.48 %) |
Mar 20 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 188.07 | 15,952 | 3,000,093 | 949,426 | 965.4 K to 949.4 K (-1.65 %) |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | O'Neill Julie | EVP. Global Operati ... | Option Exercise | A | 180.37 | 24,400 | 4,401,028 | 24,400 | |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | O'Neill Julie | EVP. Global Operati ... | Sell | S | 180.34 | 6,565 | 1,183,932 | 22,090 | 28.7 K to 22.1 K (-22.91 %) |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | O'Neill Julie | EVP. Global Operati ... | Buy | S | 0.00 | 5,100 | 0 | 28,655 | 23.6 K to 28.7 K (+21.65 %) |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Option Exercise | A | 180.37 | 24,400 | 4,401,028 | 24,400 | |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 180.34 | 487 | 87,826 | 167,321 | 167.8 K to 167.3 K (-0.29 %) |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Grant | A | 0.00 | 5,100 | 0 | 167,808 | 162.7 K to 167.8 K (+3.13 %) |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Option Exercise | A | 180.37 | 24,400 | 4,401,028 | 24,400 | |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 180.34 | 370 | 66,726 | 36,949 | 37.3 K to 36.9 K (-0.99 %) |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Grant | A | 0.00 | 5,100 | 0 | 37,319 | 32.2 K to 37.3 K (+15.83 %) |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Miller Edward | SVP, Chief Complian ... | Option Exercise | A | 180.37 | 18,300 | 3,300,771 | 18,300 | |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Miller Edward | SVP, Chief Complian ... | Grant | A | 0.00 | 3,830 | 0 | 6,830 | 3 K to 6.8 K (+127.67 %) |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Option Exercise | A | 180.37 | 5,874 | 1,059,493 | 5,874 | |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Option Exercise | A | 180.37 | 24,400 | 4,401,028 | 24,400 | |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 180.34 | 280 | 50,495 | 33,342 | 33.6 K to 33.3 K (-0.83 %) |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Grant | A | 0.00 | 1,745 | 0 | 33,622 | 31.9 K to 33.6 K (+5.47 %) |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Grant | A | 0.00 | 5,100 | 0 | 31,877 | 26.8 K to 31.9 K (+19.05 %) |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Thiel Carsten | SVP, EMEA & Asia Pa ... | Option Exercise | A | 180.37 | 18,300 | 3,300,771 | 18,300 | |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Thiel Carsten | SVP, EMEA & Asia Pa ... | Grant | A | 0.00 | 3,830 | 0 | 29,830 | 26 K to 29.8 K (+14.73 %) |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Islam Saqib | EVP, Chief Strat & ... | Option Exercise | A | 180.37 | 24,400 | 4,401,028 | 24,400 | |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Islam Saqib | EVP, Chief Strat & ... | Sell | S | 180.34 | 228 | 41,118 | 39,432 | 39.7 K to 39.4 K (-0.57 %) |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Islam Saqib | EVP, Chief Strat & ... | Grant | A | 0.00 | 5,100 | 0 | 39,660 | 34.6 K to 39.7 K (+14.76 %) |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Monnet Dominique | SVP, Chief Marketin ... | Option Exercise | A | 180.37 | 18,300 | 3,300,771 | 18,300 | |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Monnet Dominique | SVP, Chief Marketin ... | Grant | A | 0.00 | 3,830 | 0 | 9,043 | 5.2 K to 9 K (+73.47 %) |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | EVP, Chief HR Offic ... | Option Exercise | A | 180.37 | 5,874 | 1,059,493 | 5,874 | |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | EVP, Chief HR Offic ... | Option Exercise | A | 180.37 | 24,400 | 4,401,028 | 24,400 | |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | EVP, Chief HR Offic ... | Sell | S | 180.34 | 706 | 127,320 | 27,809 | 28.5 K to 27.8 K (-2.48 %) |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | EVP, Chief HR Offic ... | Grant | A | 0.00 | 1,745 | 0 | 28,515 | 26.8 K to 28.5 K (+6.52 %) |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | EVP, Chief HR Offic ... | Grant | A | 0.00 | 5,100 | 0 | 26,770 | 21.7 K to 26.8 K (+23.53 %) |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Option Exercise | A | 180.37 | 7,626 | 1,375,502 | 7,626 | |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Option Exercise | A | 180.37 | 32,200 | 5,807,914 | 32,200 | |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Sell | S | 180.34 | 730 | 131,648 | 132,858 | 133.6 K to 132.9 K (-0.55 %) |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Grant | A | 0.00 | 2,265 | 0 | 133,588 | 131.3 K to 133.6 K (+1.72 %) |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Grant | A | 0.00 | 7,290 | 0 | 131,323 | 124 K to 131.3 K (+5.88 %) |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | A | 180.37 | 98,200 | 17,712,334 | 98,200 | |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 180.34 | 1,230 | 221,818 | 965,378 | 966.6 K to 965.4 K (-0.13 %) |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Grant | A | 0.00 | 22,300 | 0 | 966,608 | 944.3 K to 966.6 K (+2.36 %) |
Feb 12 2015 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 171.15 | 1,985 | 339,733 | 162,708 | 164.7 K to 162.7 K (-1.21 %) |
Feb 12 2015 | ALXN | ALEXION PHARMACEUT ... | O'Neill Julie | EVP. Global Operati ... | Sell | S | 171.15 | 795 | 136,064 | 23,555 | 24.4 K to 23.6 K (-3.26 %) |
Feb 12 2015 | ALXN | ALEXION PHARMACEUT ... | Monnet Dominique | SVP, Chief Marketin ... | Sell | S | 171.15 | 325 | 55,624 | 5,213 | 5.5 K to 5.2 K (-5.87 %) |
Feb 12 2015 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 176.91 | 1,907 | 337,367 | 32,219 | 34.1 K to 32.2 K (-5.59 %) |
Feb 12 2015 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 171.15 | 1,990 | 340,589 | 34,126 | 36.1 K to 34.1 K (-5.51 %) |
Feb 12 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 171.15 | 1,490 | 255,014 | 26,777 | 28.3 K to 26.8 K (-5.27 %) |
Feb 12 2015 | ALXN | ALEXION PHARMACEUT ... | Islam Saqib | EVP, Chief Strat & ... | Sell | S | 171.15 | 1,500 | 256,725 | 34,560 | 36.1 K to 34.6 K (-4.16 %) |
Feb 12 2015 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | EVP, Chief HR Offic ... | Sell | S | 171.15 | 1,490 | 255,014 | 21,670 | 23.2 K to 21.7 K (-6.43 %) |
Feb 12 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Sell | S | 171.15 | 1,980 | 338,877 | 124,033 | 126 K to 124 K (-1.57 %) |
Feb 12 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 171.15 | 5,740 | 982,401 | 944,308 | 950 K to 944.3 K (-0.60 %) |
Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 175.09 | 2 | 350 | 164,693 | 164.7 K to 164.7 K (0.00 %) |
Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 174.18 | 2,701 | 470,460 | 164,695 | 167.4 K to 164.7 K (-1.61 %) |
Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Grant | A | 0.00 | 11,690 | 0 | 167,396 | 155.7 K to 167.4 K (+7.51 %) |
Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | O'Neill Julie | EVP. Global Operati ... | Grant | A | 0.00 | 4,350 | 0 | 24,350 | 20 K to 24.4 K (+21.75 %) |
Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 174.16 | 1,455 | 253,403 | 28,267 | 29.7 K to 28.3 K (-4.90 %) |